These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37800671)

  • 1. Circulating cell-free DNA and its association with cardiovascular disease: what we know and future perspectives.
    Thorsen SU; Moseholm KF; Clausen FB
    Curr Opin Lipidol; 2024 Feb; 35(1):14-19. PubMed ID: 37800671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cfDNA abundance as a prognostic biomarker for higher risk of death in geriatric cardiovascular patients.
    Cardelli M; Marchegiani F; Stripoli P; Piacenza F; Recchioni R; Di Rosa M; Giacconi R; Malavolta M; Galeazzi R; Arosio B; Cafarelli F; Spannella F; Cherubini A; Lattanzio F; Olivieri F
    Mech Ageing Dev; 2024 Jun; 219():111934. PubMed ID: 38604436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Circulating Cell-Free DNA (cfDNA) as a Biomarker of the Development and Evolution of Periodontitis.
    Viglianisi G; Santonocito S; Polizzi A; Troiano G; Amato M; Zhurakivska K; Pesce P; Isola G
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases.
    Duvvuri B; Lood C
    Front Immunol; 2019; 10():502. PubMed ID: 30941136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of periodontitis on circulating cell-free DNA levels as a measure of cardiovascular disease.
    Isola G; Polizzi A; Mascitti M; Santonocito S; Ronsivalle V; Cicciù M; Pesce P
    Clin Oral Investig; 2023 Nov; 27(11):6855-6863. PubMed ID: 37814162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases.
    Polina IA; Ilatovskaya DV; DeLeon-Pennell KY
    Clin Chim Acta; 2020 Apr; 503():145-150. PubMed ID: 31978408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Free DNA: Applications in Different Diseases.
    Ranucci R
    Methods Mol Biol; 2019; 1909():3-12. PubMed ID: 30580419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients.
    Valpione S; Gremel G; Mundra P; Middlehurst P; Galvani E; Girotti MR; Lee RJ; Garner G; Dhomen N; Lorigan PC; Marais R
    Eur J Cancer; 2018 Jan; 88():1-9. PubMed ID: 29175734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy.
    Hamfjord J; Guren TK; Dajani O; Johansen JS; Glimelius B; Sorbye H; Pfeiffer P; Lingjærde OC; Tveit KM; Kure EH; Pallisgaard N; Spindler KG
    Ann Oncol; 2019 Jul; 30(7):1088-1095. PubMed ID: 31046124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer.
    Ørntoft MW; Jensen SØ; Øgaard N; Henriksen TV; Ferm L; Christensen IJ; Reinert T; Larsen OH; Nielsen HJ; Andersen CL
    Int J Cancer; 2021 Apr; 148(7):1665-1675. PubMed ID: 33320961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective prenatal cell-free DNA screening for genetic conditions of heterogenous etiologies.
    Zhang J; Wu Y; Chen S; Luo Q; Xi H; Li J; Qin X; Peng Y; Ma N; Yang B; Qiu X; Lu W; Chen Y; Jiang Y; Chen P; Liu Y; Zhang C; Zhang Z; Xiong Y; Shen J; Liang H; Ren Y; Ying C; Dong M; Li X; Xu C; Wang H; Zhang D; Xu C; Huang H
    Nat Med; 2024 Feb; 30(2):470-479. PubMed ID: 38253798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics, properties, and potential applications of circulating cell-free dna in clinical diagnostics: a focus on transplantation.
    Sherwood K; Weimer ET
    J Immunol Methods; 2018 Dec; 463():27-38. PubMed ID: 30267663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of circulating cell-free DNA are a biomarker of active SLE.
    Xu Y; Song Y; Chang J; Zhou X; Qi Q; Tian X; Li M; Zeng X; Xu M; Zhang W; Cram DS; Liu J
    Eur J Clin Invest; 2018 Nov; 48(11):e13015. PubMed ID: 30079480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
    Cervena K; Vodicka P; Vymetalkova V
    Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free DNA and RNA-measurement and applications in clinical diagnostics with focus on metabolic disorders.
    Drag MH; Kilpeläinen TO
    Physiol Genomics; 2021 Jan; 53(1):33-46. PubMed ID: 33346689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral Blood Microbiome Analysis via Noninvasive Prenatal Testing Reveals the Complexity of Circulating Microbial Cell-Free DNA.
    Tong X; Yu X; Du Y; Su F; Liu Y; Li H; Liu Y; Mu K; Liu Q; Li H; Zhu J; Xu H; Xiao F; Li Y
    Microbiol Spectr; 2022 Jun; 10(3):e0041422. PubMed ID: 35608350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics and diagnostic applications of circulating cell-free DNA in colorectal cancer].
    Barták BK; Márkus E; Kalmár A; Galamb O; Szigeti K; Nagy ZB; Zsigrai S; Tulassay Z; Dank M; Igaz P; Molnár B
    Orv Hetil; 2019 Jul; 160(30):1167-1177. PubMed ID: 31327245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of circulating cell-free DNA and neutrophil proteins are associated with neonatal sepsis and necrotizing enterocolitis in immature mice, pigs and infants.
    Nguyen DN; Stensballe A; Lai JC; Jiang P; Brunse A; Li Y; Sun J; Mallard C; Skeath T; Embleton ND; Berrington JE; Sangild PT
    Innate Immun; 2017 Aug; 23(6):524-536. PubMed ID: 28714327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Free Nucleic Acids and their Emerging Role in the Pathogenesis and Clinical Management of Inflammatory Bowel Disease.
    Kubiritova Z; Radvanszky J; Gardlik R
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy.
    Zwirner K; Hilke FJ; Demidov G; Ossowski S; Gani C; Rieß O; Zips D; Welz S; Schroeder C
    Radiother Oncol; 2018 Dec; 129(3):575-581. PubMed ID: 30097252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.